Location History:
- San Marcos, CA (US) (2011 - 2014)
- Carlsbad, CA (US) (2014)
Company Filing History:
Years Active: 2011-2014
Title: Innovations of Douglas Eric McGrath
Introduction
Douglas Eric McGrath is a notable inventor based in San Marcos, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate tyrosine kinase activity. With a total of three patents to his name, McGrath's work has the potential to impact the treatment of various diseases.
Latest Patents
One of McGrath's latest patents focuses on tyrosine kinase inhibitors. This invention provides compounds that modulate tyrosine kinase activity, along with compositions comprising these compounds and methods for their use. Another significant patent involves heterocyclic compounds that are useful in treating neoplastic diseases, inflammatory disorders, and immunomodulatory disorders. This invention also provides compounds capable of modulating tyrosine kinases, along with their compositions and methods of use.
Career Highlights
Douglas Eric McGrath is currently associated with Chembridge Corporation, where he continues to innovate in the pharmaceutical sector. His work is characterized by a strong emphasis on developing effective treatments for complex medical conditions.
Collaborations
McGrath has collaborated with notable colleagues, including Vlad Edward Gregor and Yahua Liu. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Douglas Eric McGrath's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work in developing tyrosine kinase inhibitors and heterocyclic compounds showcases the potential for significant therapeutic advancements.